KSI-301

Kodiak's Eylea rival hits 'major disappointment' with failure in first of 6 phase 3 studies
Fierce Biotech
Wed, 02/23/22 - 09:28 pm
Kodiak Sciences
KSI-301
Eylea
Bayer
Regeneron